MYC and hepatocellular carcinoma: Collectively, our study demonstrated that a novel MYC-ZNF706-SLC7A11 regulatory circuit promotes advanced progression and regulates redox hemostasis in human hepatocellular carcinoma and especially emphasized the importance of ZNF706 involves etiopathogenesis of HCC progression and its valuable significance as a biomarker and potential therapeutic target for the HCC treatment.